pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

2,295 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT967Endpoints742BioPharma Dive283BioSpace181Fierce Biotech172onclive165globenewswire health73raps
therapy area
allOncology5617Rare Disease1251Cardiology1054Hematology939Immunology929Vaccines816Pulmonology
  • Elevance Health to Exit Unsustainable Medicaid Markets Over Next 12-18 Months
    Elevance Health, the nation's second-largest insurer, said on its Q2 earnings call it will further reduce its Medicaid business in the coming year. The move comes as several states are preparing t…
    STAT · 1mo agoNeutral↗ source
  • Uncertainty persists over food source of summer cyclospora outbreak, officials say
    A parasite called cyclospora has infected nearly 7,000 people across 34 states this summer, marking one of the largest surges on record. Michigan health officials have identified lettuce and salad…
    STAT · 1mo agoNegative↗ source
← prev
page 32 of 92
next →
65
fda recalls41
fda medwatch32
fda press25
780
Psychiatry & CNS690
Ophthalmology345
Pain342
Endocrinology & Metabolism340
Infectious Disease330
CDC reports surge in cyclosporiasis cases, over 1,600 confirmed in U.S.
The Centers for Disease Control and Prevention has confirmed more than 1,600 cases of cyclosporiasis, a parasitic infection that causes diarrhea, across the United States. An additional 5,100 cases…
STAT · 1mo agoNeutral↗ source
  • Veradermics reports first positive efficacy data for oral minoxidil in women with pattern hair loss
    Veradermics announced that its oral formulation of minoxidil demonstrated positive efficacy in a mid‑stage trial involving women with pattern hair loss. The results mark the company's first effica…
    Endpoints · 1mo agoPositive readoutPositive↗ source
  • Mwyngil Therapeutics launches obesity program that avoids GLP-1 pathway
    Mwyngil Therapeutics, a newly formed biotech startup, is pursuing obesity treatments that do not target the GLP-1 receptor, a pathway that has dominated recent weight-loss drug development. CEO Lu…
    STAT · 1mo agoNeutral↗ source
  • Scientists and stakeholders overwhelmingly oppose White House grantmaking overhaul, analysis finds
    Researchers at the University of North Carolina at Chapel Hill, working with STAT, examined a flood of public comments on a White House proposal to revamp the federal "Uniform Guidance" that govern…
    STAT · 1mo agoRegulatoryNegative↗ source
  • Senator Lindsey Graham's death from aortic dissection spotlights need for better screening
    Senator Lindsey Graham died at age 71 after suffering an aortic dissection, drawing public attention to this rare but deadly condition. An aortic dissection occurs when the body's main blood vesse…
    STAT · 1mo agoNegative↗ source
  • FTC settlement forces CVS Caremark to change insulin pricing, could save US patients $8.5 billion
    The Federal Trade Commission announced it has settled a lawsuit against CVS Caremark, one of the nation's largest pharmacy benefit managers, over claims the company inflated insulin prices and rest…
    STAT · 1mo agoRegulatoryPositive↗ source
  • CVS Caremark settles FTC antitrust case, agreeing to favor lowest-cost insulin on formularies
    CVS Caremark announced a settlement with the Federal Trade Commission that resolves the agency’s antitrust lawsuit alleging the PBM favored higher-priced insulin versions. Under the agreement, Car…
    BioPharma Dive · 1mo agoRegulatoryNeutral↗ source
  • 340B Drug Discount Program sales hit $100 billion in 2025, up 22.8% year over year
    The Health Resources and Services Administration reported that purchases under the 340B discount program reached $100 billion in 2025, a 22.8% rise from 2024. Expensive medicines made up a growing…
    STAT · 1mo agoRegulatoryNeutral↗ source
  • Celcuity receives FDA approval for Revtorpyk breast cancer therapy
    Celcuity, a small public biotech, announced that the U.S. Food and Drug Administration has cleared its drug Revtorpyk for use in breast cancer patients when combined with fulvestrant. The approval…
    Endpoints · 1mo agoApprovalPositive↗ source
  • What's next for BINSA, the House bill restricting China deals
    After setting the industry ablaze last month, a bipartisan bill aimed at restricting US biotech companies from striking deals with Chinese counterparts is in limbo. The Biotech Investment National ...
    Endpoints · 1mo ago↗ source
  • As cyclospora illnesses surge to a record, Michigan officials eye lettuce as a possible cause
    Infections from the diarrhea-causing parasite cyclospora are surging, and officials say early information points to lettuce or salad greens as a possible culprit.
    STAT · 1mo ago↗ source
  • Post-Hoc Live: What’s making biotech IPOs work again?
    Late last year, I found myself talking a lot about what it would take for biotech’s budding rally to become a full one. We had deals, good pipeline readouts and a rising public stock market ...
    Endpoints · 1mo ago↗ source
  • STAT+: Top Democrats question RFK Jr.’s health care advisory panel
    Democratic senators question presence of Trump donors, Tony Robbins on health care advisory panel.
    STAT · 1mo ago↗ source
  • STAT+: Hospital chain HCA warns of lower profits as more patients go uninsured
    It's an early indicator of the fallout from the end of extra ACA subsidies.
    STAT · 1mo ago↗ source
  • Judge orders Apple Tree partner to forfeit oversight of venture fund
    The ruling from a Cayman Islands court adds a new wrinkle to an ongoing legal dispute that’s already resulted in a bankruptcy filing — and a bid by general partner Seth Harrison for the firm’s port…
    BioPharma Dive · 1mo ago↗ source
  • Fresh off buyout, Akero execs reunite to advance long-acting psoriasis pill
    Set to go public via a reverse merger, Avere has licensed from a prolific Chinese drugmaker rights to a potential threat to medicines like Skyrizi and Icotyde.
    BioPharma Dive · 1mo ago↗ source
  • STAT+: Anthropic’s Claude Science is coming for Kendall Square
    AI still has the potential to do more than reduce corporate head counts. Watch out, Kendall Square.
    STAT · 1mo ago↗ source
  • A health tech workaround is under fire
    At the end of June, a settlement between California’s attorney general and bankrupt clinic company Carbon Health put the digital health industry on notice. The state’s Justice Department accused Ca…
    Endpoints · 1mo ago↗ source
  • Majority of new Ebola cases in eastern Congo are from unknown chains, as outbreak outpaces response
    The Ebola outbreak in eastern Congo “continues to outpace the response efforts,” the WHO’s emergencies chief said on Tuesday after returning from a trip to one of the worst hit…
    STAT · 1mo ago↗ source
  • Erasca's $550M offering; Summit sells an antibiotic
    Plus, news about subcutaneous Leqembi, WuXi AppTec and Q32 Bio. 📊 Erasca targets $550M for KRAS drugs: The biotech's public offering came after it shared a small ...
    Endpoints · 1mo ago↗ source
  • STAT+: Akero team, backed by Fairmount, launches new immunology company
    FDA approves injectable Leqembi, another post-Makary reversal, and other biotech news from The Readout
    STAT · 1mo ago↗ source
  • Chai Discovery gets $400M, tripling valuation from seven months ago
    Chai Discovery, one of the hottest startups in the AI-generated drug discovery landscape, has corralled $400 million in a Series C that triples its paper value from its last round of financing. In…
    Endpoints · 1mo ago↗ source
  • Draig bags another $65M to speed testing of brain drugs
    The cash will support mid-stage trials of a prospect the company claims to have “best-in-disease” potential treating major depressive disorder.
    BioPharma Dive · 1mo ago↗ source